H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Tweet Send to a Friend
H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating and $70.00 price target on Definium Therapeutics Inc (NASDAQ: DFTX).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


